Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience
Open Access
- 10 May 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 8 (2) , 33
Abstract
Screening for severe combined immunodeficiency (SCID) was added to the New Zealand national newborn screening programme in December 2017. Documentation pertaining to the application to add SCID to the panel and screening results over the first three years were reviewed. Screening evaluation metrics were shown to differ according to site of collection (babies in a neonatal intensive care unit vs. the community), definition of a positive test (out-of-range result vs. result leading to a further action on baby), and screening target/case definition (primary SCID vs. non-SCID T-cell lymphopenia). Our experience demonstrates both the value of close clinical involvement during the implementation phase of SCID screening and that the use of standard definitions will facilitate international comparison.Keywords
This publication has 6 references indexed in Scilit:
- Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2021
- Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined ImmunodeficiencyFrontiers in Immunology, 2020
- Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010–2017Pediatrics, 2019
- The decision to discontinue screening for carnitine uptake disorder in New ZealandJournal of Inherited Metabolic Disease, 2019
- Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experienceJournal of Allergy and Clinical Immunology, 2014
- Challenges of Newborn Severe Combined Immunodeficiency Screening Among Premature InfantsPediatrics, 2013